Drug Shortages Reveal GMP Concerns

FDA cites manufacturing difficulties as a main contributing factor to recent drug shortages, which mainly involve injectibles and vaccines.

Related Content:

Quality SystemsRegulatory Oversight and CompliancePharmaceutical Technology-06-02-2002

Ask the Expert: Adventitious Contamination Control

European Pharmacopoeia Goes Digital

Six Biosimilars Part of EMA’s Authorization Recommendations in June